"ChatGPT: Revolutionizing Medicine Design with AI Coding"

Scientists at Chapman University have developed a GenAI model called drugAI, which utilizes advanced AI techniques to design new drug compounds with the right properties and characteristics, promising to accelerate the process of identifying viable drug candidates for various diseases at a fraction of the cost. The model has been tested and validated, showing magnificent results and generating potential drugs that have never been conceived of before. It has also demonstrated a high validity rate, drug-likeness, and strong binding affinities to respective targets, making it a promising tool for future drug design and development.